Frank A. Oski Memorial Lectureship
The purpose of the annual Frank A. Oski Memorial Lectureship is to honor Dr. Oski's many contributions to the field of pediatric hematology/oncology and ensure a younger generation of pediatric hematology/oncology specialists remains aware of his legacy. The lectureship is awarded to an outstanding clinical or laboratory investigator in pediatric hematology/oncology whose cutting-edge research is of the caliber of the investigations made by Dr. Oski.
The 2025 ASPHO Awards will be presented at the 2025 ASPHO Conference, May 7-10, in Louisville, KY.
ASPHO Awards are open year-round for nomination and application. Applications submitted between October 2, 2024 and September 30, 2025 will be considered for the 2026 awards cycle and presented at the 2026 ASPHO Conference in Minneapolis, MN.
2025 Recipient
Ayesha Zia, MD MSCS
UT Southwestern Medical Center
Dallas, TX
Eligibility:
The Frank A. Oski Memorial Lectureship is presented annually to an accomplished clinical or research scientist with an MD, PhD or MD/PhD degree, and while it is not required, ideally they would be a board certified pediatric hematology/oncology specialist. The recipient should be in early or mid-career, be known as an excellent speaker and investigator, and must agree to present a 35-45 minute state-of-the-art lecture describing his/her research at the ASPHO Conference. The recipient need not be a member of ASPHO.
The individual chosen for this award must agree to present a 35-45 minute during the ASPHO Conference career retrospective highlighting his/her career accomplishments and how mentoring and teaching played a role in that journey.
Past Recipients
2024 Nirali N. Shah, MD
National Cancer Institute
Rockville, MD
2023 Saro Armenian, DO MPH
City of Hope
Duarte, CA
2022 Yael P. Mossé, MD
Children's Hospital of Philadelphia
Philadelphia, PA
2019 Akiko Shimamura, MD PhD
Boston Children's Hospital
Boston, MA
2019 Wilbur Lam, MD PhD
Aflac Cancer & Blood Disorders Center/Emory University
Atlanta, GA
2018 Julie R. Park, MD
Children’s Hospital & Medical Center
Seattle, WA
Improvements in Neuroblastoma Therapy: The Fruits of Collaboration
2017 Alexis A. Thompson, MD MPH
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL
Advances in Hemoglobinopathies
2016 Joanne Wolfe, MD MPH
Dana-Farber Cancer Institute
Boston, MA
Easing Suffering, Enhancing Well-Being: A Program of Research Guided by Pediatric Palliative Care Principles
2015 Stephan A. Grupp, MD PhD
Children's Hosital of Philadelphia
Philadephia, PA
Novel Therapies for Pediatric Leukemia
2014 Scott A. Armstrong, MD PhD
Memorial Sloan-Kettering Cancer Center
New York, NY
MLL-Rearranged Leukemias: Stem Cells, Histone Modifications, and New Therapies
2013 Jorge DiPaola, MD
Children's Hospital Colorado
Aurora, CO
Platelets and Von Willebrand Factor: An Axis of Good and (Sometimes) Evil
2012 Lillian Sung, MD PhD
Hospital for Sick Children
Toronto, ON, Canada
Decision Making in Pediatric Oncology: Evaluation and Incorporation of Patient and Parent Preferences
2011 Mignon Loh, MD
University of California, San Francisco
San Francisco, CA
Lessons Learned from Studying Children with Hematopoietic Malignancies
2010 Smita Bhatia, MD MPH
City of Hope National Medical Center
Arcadia, CA
Pediatric Cancer Survivorship: Some Well-Traveled Paths—Yet Miles to Go...
2009 Donald Small, MD PhD
FLT3: Biology and Targeting in Leukemia
2008 Todd Golub, MD
Genomic Signatures and Cancer
2007 John Maris, MD
Translating our Evolving Knowledge of Neuroblastoma Biology to Patients with the Disease
2006 David Williams, MD
Cell-Cell Interactions in the Bone Marrow: How Basic Studies in Stem Cell Biology Informed New Therapeutics in Cancer and Gene Therapy
2005 Thomas Look, MD
The Emerging Genetics of T-Cell ALL in Children and Adolescents
2004 Russell Ware, MD PhD
Hydroxyurea for Children with Sickle-cell Disease: Fact, Fiction, and Fantasy
2003 Stuart Orkin, MD
Journey from Thalassemia to Stem Cells
2002 George Dover, MD
Pediatric Hematology/Oncology: A Look into the Future